AAV-HBV recombinant virus based on S gene cleavage, and establishment method and application of hepatitis B virus mouse model
An AAV-HBV, AAV-HBV1.04 technology, applied in the direction of single-stranded DNA virus, retro DNA virus, virus, etc., can solve the problem of not being HBV cccDNA, unable to judge the role of cccDNA, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0035] The pAAV-HBV1.2 and pAAV-HBV1.04 plasmids were constructed. The pAAV-HBV 1.04 plasmid was constructed by homologous recombination technology, see the schematic diagram figure 1 , the pAAV-HBV1.04 vector plasmid sequence is shown in SEQ ID NO.3. Select the small S region of the HBV genome rcDNA as the starting point and extend along the HBV genome rcDNA back to the starting point and then about 127 bp (homologous arm) as the end point. The obtained HBV genome DNA length divided by 3182 is 1.04 copies. The selection of the starting point and the end point can change back and forth in the small S area.
[0036] 1. Amplification of AAV linearized vector backbone fragment and HBV target fragment by PCR technology
[0037]The template used to amplify the AAV vector backbone is pAAV-TBG>hSLC10A1[NM_003049.3]:WPRE (the AAV vector backbone sequence is a commonly used sequence). The template used to amplify the HBV target fragment is the plasmid containing HBV1.3 ploid or dipl...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com